HLA-DRw antigens associated with acute leukemia

Tissue Antigens
V E von FliednerM Jeannet

Abstract

In mice, susceptibility to leukemia is closely linked to "Ia" antigens coded by the major histocompatibility complex and is transmitted recessively. To test this hypothesis in man, 89 patients with acute leukemia were typed for the eight known HLA-DRw specificities, representing the human counterpart of the Ia system, and compared with a normal unrelated control population (n=123). Phenotypes showing only one identifiable DRw antigen were significantly increased in patients with acute leukemia. Within such phenotypes, there was a predominant and significant occurrence of DRw antigens 3, 6, and 7, depending on the type of leukemia (AML, ALL in adults, and ALL in children respectively). These findings are most probably due to an excess of homozygotes for these particular DRw antigens, thus suggesting a recessive mode of transmission of susceptibility to leukemia in man.

References

Jun 1, 1978·Journal of the National Cancer Institute·F W GunzR L Kirk
Apr 1, 1977·Tissue Antigens·C WernerM Jeannet
Aug 1, 1978·Annals of Internal Medicine·W A BlattnerJ F Fraumeni
Sep 1, 1978·British Medical Bulletin·R HarrisR T Oliver
Sep 1, 1978·British Medical Bulletin·W F Bodmer, J G Bodmer
Jan 1, 1974·Tissue Antigens·A SvejgaardW F Bodmer
Jan 1, 1969·Advances in Immunology·H O McDevitt, B Benacerraf
Jun 1, 1955·Annals of Human Genetics·B WOOLF

❮ Previous
Next ❯

Citations

Sep 19, 1991·The New England Journal of Medicine·J N Bouwes BavinckF H Claas
Sep 1, 1986·British Journal of Haematology·M F Greaves, L C Chan
Mar 24, 2015·Molecular and Clinical Oncology·Mervat M El AnsaryAlshymaa A Ahmed
Sep 1, 1982·British Journal of Haematology·B M de JonghG M Schreuder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.